Oncosite - Centro de Pesquisa Clinica em Oncologia

Ijuí 98700-000

2 studies enrolling now · 7 studies all time

What they study most

Advanced Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Metastatic Colorectal Cancer, Metastatic Head and Neck Cancer, Neoplasm Metastasis, Non-Small Cell Lung Cancer, PD-L1 Negative, Recurrent Head and Neck Cancer, Triple Negative Breast Cancer, Unresectable Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma — Running, not enrolling
• A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer — Running, not enrolling